Pipeline

Strong R&D, select partnerships, significant investment.

Our R&D strategy for a thriving product pipeline

As a global biopharmaceutical company with a focus on innovation and specialty care, Ipsen is building a strong and sustainable portfolio of medicines to meet patients’ and their healthcare teams’ needs. We prioritize best-in-class and first-in-class treatments in oncology, rare disease, and neuroscience – areas in which we have proven experience, global capabilities, and a strong network of partners.

Key facts

Building a high-value, sustainable pipeline

Filters

Disease Areas

Phase

Download pipeline chart

Group By

Oncology

Rare disease

Neuroscience

Phase – l

Phase – ll

Phase – lll

Registration

Oncology

1

IPN60210

R/R multiple myeloma and R/R DLBCL

CABOMETYX + ATEZOLIZUMAB

2L mCRPC

TAZVERIK + R2

2L FL

ONIVYDE + 5-FU/LV + OXALIPLATIN

1L mPDAC

Rare disease

2

IPN60260

Viral cholestatic disease

FIDRISERTIB

FOP

ELAFIBRANOR

PSC

IPN60250

PSC

BYLVAY

Biliary atresia

ODEVIXIBAT1

Alagille syndrome

ELAFIBRANOR

2L PBC

Neuroscience

3

IPN10200

Longer-acting neurotoxin Ax

IPN10200

Longer-acting neurotoxin Tx

DYSPORT

Chronic and episodic migraine

Information shown as at end of January 2024

R/Rrelapsed/refractory
DLBCLdiffuse large B-cell lymphoma
FOPfibrodysplasia ossificans progressiva
PSCprimary sclerosing cholangitis
Axaesthetics
Txtherapeutics
R2lenalidomide + rituximab
2Lsecond line
mCRPCmetastatic castration-resistant prostate cancer
FLfollicular lymphoma
1Lfirst line
mPDACmetastatic pancreatic ductal adenocarcinoma
PBCprimary biliary cholangitis
1 E.U.

CLINICAL TRIALS

Help develop Ipsen products by participating in clinical trials: clinical trials in all phases require volunteers to test the efficacy and safety of new drugs. They offer an opportunity to contribute to advancing medicine and improving health outcomes for patients worldwide.

INVESTORS

INVESTORS

Ipsen provides comprehensive investor information, including our financial updates, reports and events calendar, plus shareholder news and regulated information in our dedicated investor pages.

OUR PARTNERSHIPS

OUR PARTNERSHIPS

At Ipsen, we believe that partnerships create possibilities. We seek to build partnerships that boost our capacity to improve or extend the lives of people living with cancer, rare diseases and neurological conditions.